These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 33085059)

  • 1. The function and regulation of TET2 in innate immunity and inflammation.
    Cong B; Zhang Q; Cao X
    Protein Cell; 2021 Mar; 12(3):165-173. PubMed ID: 33085059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TET2 as an epigenetic master regulator for normal and malignant hematopoiesis.
    Nakajima H; Kunimoto H
    Cancer Sci; 2014 Sep; 105(9):1093-9. PubMed ID: 25040794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The TET2 interactors and their links to hematological malignancies.
    Pan F; Weeks O; Yang FC; Xu M
    IUBMB Life; 2015 Jun; 67(6):438-45. PubMed ID: 26099018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tet2 promotes pathogen infection-induced myelopoiesis through mRNA oxidation.
    Shen Q; Zhang Q; Shi Y; Shi Q; Jiang Y; Gu Y; Li Z; Li X; Zhao K; Wang C; Li N; Cao X
    Nature; 2018 Feb; 554(7690):123-127. PubMed ID: 29364877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The methylcytosine dioxygenase Tet2 promotes DNA demethylation and activation of cytokine gene expression in T cells.
    Ichiyama K; Chen T; Wang X; Yan X; Kim BS; Tanaka S; Ndiaye-Lobry D; Deng Y; Zou Y; Zheng P; Tian Q; Aifantis I; Wei L; Dong C
    Immunity; 2015 Apr; 42(4):613-26. PubMed ID: 25862091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TET2 promotes IL-1β expression in J774.1 cell through TLR4/MAPK signaling pathway with demethylation of TAB2 promoter.
    Liang Y; Zeng J; Luo B; Li W; He Y; Zhao W; Hu N; Jiang N; Luo Y; Xian Y; Liu J; Zheng X
    Mol Immunol; 2020 Oct; 126():136-142. PubMed ID: 32823238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TET proteins and 5-methylcytosine oxidation in hematological cancers.
    Ko M; An J; Pastor WA; Koralov SB; Rajewsky K; Rao A
    Immunol Rev; 2015 Jan; 263(1):6-21. PubMed ID: 25510268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tet2 at the interface between cancer and immunity.
    Jiang S
    Commun Biol; 2020 Nov; 3(1):667. PubMed ID: 33184433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TET2 in Normal and Malignant Hematopoiesis.
    Bowman RL; Levine RL
    Cold Spring Harb Perspect Med; 2017 Aug; 7(8):. PubMed ID: 28242787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylcytosine dioxygenase ten-eleven translocation 2 enhances lipopolysaccharide-induced cytokine expression in human dental pulp cells by regulating MyD88 hydroxymethylation.
    Wang X; Feng Z; Li Q; Yi B; Xu Q
    Cell Tissue Res; 2018 Aug; 373(2):477-485. PubMed ID: 29654353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TET2: A Novel Epigenetic Regulator and Potential Intervention Target for Atherosclerosis.
    Liu Y; Peng W; Qu K; Lin X; Zeng Z; Chen J; Wei D; Wang Z
    DNA Cell Biol; 2018 Jun; 37(6):517-523. PubMed ID: 29653065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic Function of TET Family, 5-Methylcytosine, and 5-Hydroxymethylcytosine in Hematologic Malignancies.
    Li W; Xu L
    Oncol Res Treat; 2019; 42(6):309-318. PubMed ID: 31055566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulation of TET2 in hematologic malignancies.
    Chiba S
    Int J Hematol; 2017 Jan; 105(1):17-22. PubMed ID: 27848178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [TET2 gene in hematological diseases].
    Li S; Wang XQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):836-41. PubMed ID: 24989305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MBD3L2 promotes Tet2 enzymatic activity for mediating 5-methylcytosine oxidation.
    Peng L; Li Y; Xi Y; Li W; Li J; Lv R; Zhang L; Zou Q; Dong S; Luo H; Wu F; Yu W
    J Cell Sci; 2016 Mar; 129(5):1059-71. PubMed ID: 26769901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [TET2 as a gatekeeper for hematologic malignancies].
    Muto H; Sakata-Yanagimoto M; Chiba S
    Rinsho Ketsueki; 2015 Jun; 56(6):651-6. PubMed ID: 26256875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic silencing of TET2 and TET3 induces an EMT-like process in melanoma.
    Gong F; Guo Y; Niu Y; Jin J; Zhang X; Shi X; Zhang L; Li R; Chen L; Ma RZ
    Oncotarget; 2017 Jan; 8(1):315-328. PubMed ID: 27852070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of high 5-hydroxymethylcytosine levels with Ten Eleven Translocation 2 overexpression and inflammation in Sjögren's syndrome patients.
    Lagos C; Carvajal P; Castro I; Jara D; González S; Aguilera S; Barrera MJ; Quest AFG; Bahamondes V; Molina C; Urzúa U; Hermoso MA; Leyton C; González MJ
    Clin Immunol; 2018 Nov; 196():85-96. PubMed ID: 29894742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Ten-Eleven Translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases.
    Solary E; Bernard OA; Tefferi A; Fuks F; Vainchenker W
    Leukemia; 2014 Mar; 28(3):485-96. PubMed ID: 24220273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6.
    Zhang Q; Zhao K; Shen Q; Han Y; Gu Y; Li X; Zhao D; Liu Y; Wang C; Zhang X; Su X; Liu J; Ge W; Levine RL; Li N; Cao X
    Nature; 2015 Sep; 525(7569):389-393. PubMed ID: 26287468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.